Mouse models of nonalcoholic fatty liver disease (NAFLD): pathomechanisms and pharmacotherapies

The prevalence of non-alcoholic fatty liver disease (NAFLD) increases year by year, and as a consequence, NAFLD has become one of the most prevalent liver diseases worldwide. Unfortunately, no pharmacotherapies for NAFLD have been approved by the United States Food and Drug Administration despite pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Fang, Tingyu, Wang, Hua, Pan, Xiaoyue, Little, Peter J., Xu, Suowen, Weng, Jianping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9576517/
https://www.ncbi.nlm.nih.gov/pubmed/36263163
http://dx.doi.org/10.7150/ijbs.65044

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9576517/
https://www.ncbi.nlm.nih.gov/pubmed/36263163
http://dx.doi.org/10.7150/ijbs.65044

Ejemplares similares